0QAI.LSE Adocia
- Market cap
- EUR 33.9M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2021.
Is 0QAI.LSE undervalued?
Graham numberThe Graham number of Adocia cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Adocia fundamental analysis
No fundamental analysis for Adocia yet.
Adocia stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Adocia
Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. The company's proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company provides BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid prandial insulin lispro; BioChaperone GLP-1 Amylin, a combination of acting insulin glargine and rapid-acting insulin lispro, as well a…
Full company profileAdocia financial statements
2021 annualized: Fiscal year 2021 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2021, the balance sheet is the latest quarter. Figures change when the annual report is published.
Adocia annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 Anlz |
|---|---|---|---|---|---|
| Cash Flow | |||||
| Operating Cash Flow | -22.2M | 6.31M | -9.66M | -21.9M | - |
| Capital Expenditure | 1.98M | 784K | 2.02M | 205K | - |
What these items mean
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
Adocia dividends
Adocia has not paid dividends in the last 8 fiscal years.
Who owns Adocia
- Insiders 9.09%
- Institutions 7.22%
- Public & others 83.69%
- Shares outstanding 6.89M
- Free float 16.7M
Adocia company profile
- Company name
- Adocia
- Ticker
- 0QAI.LSE
- ISIN
- FR0011184241
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Oil, Gas & Consumable Fuels
- Employees
- 80
- Fiscal year end
- December
- Address
- 115 Avenue Lacassagne, Lyon, France, 69003
- Phone
- 33 4 72 61 06 10
- Website
- adocia.com
About Adocia
Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. The company's proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company provides BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid prandial insulin lispro; BioChaperone GLP-1 Amylin, a combination of acting insulin glargine and rapid-acting insulin lispro, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity, including AdoShell Islets, an ultra rapid insulin; AdOral Sema, an oral form of GLP-1 semaglutide; and AdoXLongSem, a long-lasting injectable formulation of semaglutide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
Adocia management
8- Mr. Olivier Soula M.B.A., Ph.D.Co-Founder, CEO & Director · born 1970
- Mr. Mathieu-William GilbertCOO & CFO
- Jeremy Benattar Eng., Pharm.D.Marketing & Strategy Director
- Ms. Geraldine Favre SoulaDirector of Human Resources
- Dr. Bertrand AlluisHead of the Analysis Department and Project Manager
- Dr. David DuracherHead of the Pharmaceutical Development & Physical Chemistry Departments and Project Manager
- Dr. Richard CharvetHead of Chemistry Department & Project Manager
- Dr. Grégory MeiffrenHead of the Biology Department & Project Manager